Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 25:12:1019750.
doi: 10.3389/fonc.2022.1019750. eCollection 2022.

Emerging roles of alternative RNA splicing in oral squamous cell carcinoma

Affiliations
Review

Emerging roles of alternative RNA splicing in oral squamous cell carcinoma

Miaomiao Liu et al. Front Oncol. .

Abstract

Alternative RNA splicing (ARS) is an essential and tightly regulated cellular process of post-transcriptional regulation of pre-mRNA. It produces multiple isoforms and may encode proteins with different or even opposite functions. The dysregulated ARS of pre-mRNA contributes to the development of many cancer types, including oral squamous cell carcinoma (OSCC), and may serve as a biomarker for the diagnosis and prognosis of OSCC and an attractive therapeutic target. ARS is mainly regulated by splicing factors, whose expression is also often dysregulated in OSCC and involved in tumorigenesis. This review focuses on the expression and roles of splicing factors in OSCC, the alternative RNA splicing events associated with OSCC, and recent advances in therapeutic approaches that target ARS.

Keywords: OSCC; alternative splicing; splicing factor; therapeutic targets; tumor progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The common types of alternative RNA splicing and the SF3b complex involved in alternative RNA splicing. (A) The different types of alternative RNA splicing and transcript variants (exon skipping, intron retention, mutually exclusive exons, alternative 5’ splice site, and alternative 3’ splice site). (B) Diagram of the components of spliceosome complex, especially SF3b complex, and SF3b1-specific inhibitors.
Figure 2
Figure 2
Alternative RNA splicing and splicing factors regulate OSCC cell proliferation, invasion, and EMT.

Similar articles

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2018) 68(6):394–424. doi: 10.3322/caac.21492 - DOI - PubMed
    1. Zhang S, Wu X, Diao P, Wang C, Wang D, Li S, et al. . Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. J Cell Physiol (2020) 235(5):4804–13. doi: 10.1002/jcp.29357 - DOI - PubMed
    1. Bonnal SC, Lopez-Oreja I, Valcarcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol (2020) 17(8):457–74. doi: 10.1038/s41571-020-0350-x - DOI - PubMed
    1. Alt FW, Bothwell AL, Knapp M, Siden E, Mather E, Koshland M, et al. . Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mrnas that differ at their 3' ends. Cell (1980) 20(2):293–301. doi: 10.1016/0092-8674(80)90615-7 - DOI - PubMed
    1. Early P, Rogers J, Davis M, Calame K, Bond M, Wall R, et al. . Two mrnas can be produced from a single immunoglobulin mu gene by alternative rna processing pathways. Cell (1980) 20(2):313–9. doi: 10.1016/0092-8674(80)90617-0 - DOI - PubMed

LinkOut - more resources